Ingevity Corp Valuation – March 2018 $NGVT

Company Profile (obtained from Marketwatch): Ingevity Corp engages in the manufacture of specialty chemicals and carbon materials. It operates through the Performance Chemicals and Performance Materials segments. The Performance Materials segment consists of carbon technologies business which primarily produces automotive carbon products used in gasoline vapor emission control systems. The Performance Chemicals segment primarily addresses applications in three product families: pavement technologies, oilfield technologies, and industrial specialties. The company was founded on March 27, 2015 and is headquartered in North Charleston, SC.

NGVT Chart

NGVT data by YCharts


Downloadable PDF version of this valuation:

ModernGraham Valuation of NGVT – March 2018

Stage 1: Is this company suitable for the Defensive Investor or the Enterprising Investor?

What kind of Intelligent Investor are you?

Defensive Investor; must pass 6 out of the following 7 tests.
1. Adequate Size of the Enterprise Market Cap > $2Bil $3,300,167,863 Pass
2. Sufficiently Strong Financial Condition Current Ratio > 2 2.41 Pass
3. Earnings Stability Positive EPS for 10 years prior Fail
4. Dividend Record Dividend Payments for 10 years prior Fail
5. Earnings Growth Increase of 33% in EPS in past 10 years using 3 year averages at beginning and end 22866.67% Pass
6. Moderate PEmg Ratio PEmg < 20 32.06 Fail
7. Moderate Price to Assets PB Ratio < 2.5 OR PB*PEmg < 50 12.64 Fail
Enterprising Investor; must pass 4 out of the following 5 tests, or be suitable for the Defensive Investor.
1. Sufficiently Strong Financial Condition Current Ratio > 1.5 2.41 Pass
2. Sufficiently Strong Financial Condition Debt to NCA < 1.1 0.00 Pass
3. Earnings Stability Positive EPS for 5 years prior Pass
4. Dividend Record Currently Pays Dividend Fail
5. Earnings Growth EPSmg greater than 5 years ago Pass


Stage 2: Determination of Intrinsic Value

EPSmg $2.44
MG Growth Estimate 15.00%
MG Value $94.09
Opinion Fairly Valued
MG Grade C
MG Value based on 3% Growth $35.44
MG Value based on 0% Growth $20.77
Market Implied Growth Rate 11.78%
Current Price $78.36
% of Intrinsic Value 83.28%

Ingevity Corp is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the insufficient earnings stability over the last ten years, and the poor dividend history, and the high PEmg and PB ratios. The Enterprising Investor is only concerned with the lack of dividends. As a result, all Enterprising Investors following the ModernGraham approach should feel comfortable proceeding with the analysis.

As for a valuation, the company appears to be Fairly Valued after growing its EPSmg (normalized earnings) from $1.02 in 2014 to an estimated $2.44 for 2018. This level of demonstrated earnings growth supports the market’s implied estimate of 11.78% annual earnings growth over the next 7-10 years. As a result, the ModernGraham valuation model, based on the Benjamin Graham value investing formula, returns an estimate of intrinsic value within a margin of safety relative to the price.

At the time of valuation, further research into Ingevity Corp revealed the company was trading above its Graham Number of $20.88. The company does not pay a dividend. Its PEmg (price over earnings per share – ModernGraham) was 32.06, which was above the industry average of 31.55. Finally, the company was trading above its Net Current Asset Value (NCAV) of $-6.98.

Ingevity Corp receives an average overall rating in the ModernGraham grading system, scoring a C.

Stage 3: Information for Further Research

Net Current Asset Value (NCAV) -$6.98
Graham Number $20.88
PEmg 32.06
Current Ratio 2.41
PB Ratio 12.64
Current Dividend $0.00
Dividend Yield 0.00%
Number of Consecutive Years of Dividend Growth 0

Useful Links:

ModernGraham tagged articles Morningstar
Google Finance MSN Money
Yahoo Finance Seeking Alpha
GuruFocus SEC Filings

Most Recent Balance Sheet Figures

Balance Sheet Information 12/1/2017
Total Current Assets $368,700,000
Total Current Liabilities $153,200,000
Long-Term Debt $0
Total Assets $929,600,000
Intangible Assets $17,300,000
Total Liabilities $665,700,000
Shares Outstanding (Diluted Average) 42,556,000

Earnings Per Share History

EPS History
Next Fiscal Year Estimate $3.09
Dec2017 $2.97
Dec2016 $0.83
Dec2015 $1.89
Dec2014 $3.06

Earnings Per Share – ModernGraham History

EPSmg History
Next Fiscal Year Estimate $2.44
Dec2017 $2.00
Dec2016 $1.39
Dec2015 $1.45
Dec2014 $1.02

Recommended Reading:

Other ModernGraham posts about the company

Ingevity Corp Valuation – Initial Coverage $NGVT

Other ModernGraham posts about related companies

Eastman Chemical Co Valuation – March 2018 $EMN
LyondellBasell Industries NV Valuation – March 2018 $LYB
DowDuPont Inc Valuation – February 2018 $DWDP
Green Plains Inc Valuation – Initial Coverage $GPRE
PolyOne Corp Valuation – Initial Coverage $POL
Ingevity Corp Valuation – Initial Coverage $NGVT
Praxair Inc Valuation – August 2017 $PX
Albemarle Corp Valuation – March 2017 $ALB
Sensient Technologies Corp Valuation – Initial Coverage $SXT
Quaker Chemical Corp Valuation – Initial Coverage $KWR


The author did not hold a position in any company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours.  See my current holdings here.  This article is not investment advice; any reader should speak to a registered investment adviser prior to making any investment decisions.  ModernGraham is not affiliated with the company in any manner.  Please be sure to review our detailed disclaimer.






Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.